These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11891194)

  • 21. Effects of NSAIDs on cryoprobe-induced gastric ulcer healing in rats.
    Tibble J; Sigthorsson G; Caldwell C; Palmer RH; Bjarnason I
    Aliment Pharmacol Ther; 2001 Dec; 15(12):2001-8. PubMed ID: 11736732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2.
    Hsu AL; Ching TT; Wang DS; Song X; Rangnekar VM; Chen CS
    J Biol Chem; 2000 Apr; 275(15):11397-403. PubMed ID: 10753955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using cyclooxygenase-2 inhibitors as molecular platforms to develop a new class of apoptosis-inducing agents.
    Zhu J; Song X; Lin HP; Young DC; Yan S; Marquez VE; Chen CS
    J Natl Cancer Inst; 2002 Dec; 94(23):1745-57. PubMed ID: 12464646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma.
    Badawi AF; Eldeen MB; Liu Y; Ross EA; Badr MZ
    Cancer Res; 2004 Feb; 64(3):1181-9. PubMed ID: 14871855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors.
    Kusunoki N; Yamazaki R; Kawai S
    Arthritis Rheum; 2002 Dec; 46(12):3159-67. PubMed ID: 12483719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Celecoxib derivatives induce apoptosis via the disruption of mitochondrial membrane potential and activation of caspase 9.
    Ding H; Han C; Zhu J; Chen CS; D'Ambrosio SM
    Int J Cancer; 2005 Feb; 113(5):803-10. PubMed ID: 15499625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wound collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor.
    Muscará MN; McKnight W; Asfaha S; Wallace JL
    Br J Pharmacol; 2000 Feb; 129(4):681-6. PubMed ID: 10683192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyaluronan increases glomerular cyclooxygenase-2 protein expression in a p38 MAP-kinase-dependent process.
    Dunlop ME; Muggli EE
    Kidney Int; 2002 May; 61(5):1729-38. PubMed ID: 11967022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
    Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M
    Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of rebamipide on acetic acid-induced gastric ulcer in rats: involvement of hepatocyte growth factor.
    Udagawa A; Shiota G; Ichiba M; Murawaki Y
    Scand J Gastroenterol; 2003 Feb; 38(2):141-6. PubMed ID: 12678329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells.
    Abiru S; Nakao K; Ichikawa T; Migita K; Shigeno M; Sakamoto M; Ishikawa H; Hamasaki K; Nakata K; Eguchi K
    Hepatology; 2002 May; 35(5):1117-24. PubMed ID: 11981761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis.
    Goldenberg MM
    Clin Ther; 1999 Sep; 21(9):1497-513; discussion 1427-8. PubMed ID: 10509845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ellagic acid facilitates indomethacin-induced gastric ulcer healing via COX-2 up-regulation.
    Chatterjee A; Chatterjee S; Das S; Saha A; Chattopadhyay S; Bandyopadhyay SK
    Acta Biochim Biophys Sin (Shanghai); 2012 Jul; 44(7):565-76. PubMed ID: 22626975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclo-oxygenase-2 expression and prostaglandin E2 production in experimental chronic gastric ulcer healing.
    Poonam D; Vinay CS; Gautam P
    Eur J Pharmacol; 2005 Sep; 519(3):277-84. PubMed ID: 16139265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage.
    Fiorucci S; de Lima OM; Mencarelli A; Palazzetti B; Distrutti E; McKnight W; Dicay M; Ma L; Romano M; Morelli A; Wallace JL
    Gastroenterology; 2002 Nov; 123(5):1598-606. PubMed ID: 12404234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.
    Silverstein FE; Faich G; Goldstein JL; Simon LS; Pincus T; Whelton A; Makuch R; Eisen G; Agrawal NM; Stenson WF; Burr AM; Zhao WW; Kent JD; Lefkowith JB; Verburg KM; Geis GS
    JAMA; 2000 Sep; 284(10):1247-55. PubMed ID: 10979111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice.
    Mizuno H; Sakamoto C; Matsuda K; Wada K; Uchida T; Noguchi H; Akamatsu T; Kasuga M
    Gastroenterology; 1997 Feb; 112(2):387-97. PubMed ID: 9024292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclooxygenase-2 (COX-2) inhibition limits abnormal COX-2 expression and progressive injury in the remnant kidney.
    Fujihara CK; Antunes GR; Mattar AL; Andreoli N; Malheiros DM; Noronha IL; Zatz R
    Kidney Int; 2003 Dec; 64(6):2172-81. PubMed ID: 14633140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nitric oxide (NO)-releasing aspirin exhibits a potent esophagoprotection in experimental model of acute reflux esophagitis. Role of nitric oxide and proinflammatory cytokines.
    Pawlik M; Pajdo R; Kwiecien S; Ptak-Belowska A; Sliwowski Z; Mazurkiewicz-Janik M; Konturek SJ; Pawlik WW; Brzozowski T
    J Physiol Pharmacol; 2011 Feb; 62(1):75-86. PubMed ID: 21451212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model.
    Ayalasomayajula SP; Kompella UB
    Eur J Pharmacol; 2003 Jan; 458(3):283-9. PubMed ID: 12504784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.